Yesterday, the Democratic Senatorial Campaign Committee blasted out its latest news release on what it’s terming “sabotage” by Republicans on health care. There’s actually evidence that marketplace plans are regaining some profitability. And when health insurance plans don’t pay, patients are left with burdensome bills,” Sarah writes. Scott Applewhite)— It's too hard for cheaper drugs known as biosimilars to get covered by insurance plans, FDA Commissioner Scott Gottlieb said yesterday at an event hosted by the Atlantic. Rebate agreements between insurance plans and pharmaceutical companies, Gottlieb said.

Source: Washington Post May 24, 2018 12:22 UTC